Pancreatic Cancer Treatment Market
Report ID: SQMIG35I2262
Report ID:
SQMIG35I2262 |
Region:
Global |
Published Date: July, 2001
Pages:
165
|Tables:
149
|Figures:
78
Pancreatic Cancer Treatment Market size was valued at USD 2.15 billion in 2022 and is poised to grow from USD 2.48 billion in 2023 to USD 6.85 billion by 2031, growing at a CAGR of 15.7% in the forecast period (2024-2031).
Tumors are generally described as lumps of tissue that occur as a result of aberrant, uncontrolled cell proliferation. The pancreas cannot function normally when malignancies are present. The unchecked proliferation of cancerous cells, or in the tissues of the pancreas is known as pancreatic cancer. The pancreas develops tumours as a result of the cancerous cells, which prevents the organ from operating normally.
The pancreatic cancer treatment market is expected to expand quickly during the coming years. According to the American Cancer Society, pancreatic cancer makes up roughly 3% of all cancer cases in the United States (ACS). According to the American Cancer Society, around 33% of population suffered from pancreatic cancer in 2019. Due to its difficulty in detection, pancreatic cancer typically only becomes known when it has advanced to an advanced stage. Two signs of pancreatic cancer include jaundice and weight loss. Risk factors include having diabetes and being exposed to certain chemicals. Depending on the tumor size, location, and whether it has spread to other bodily areas, a certain treatment may be appropriate.
The market expansion is primarily the result of businesses restructuring their operations and recovering from the COVID-19 effect, which had previously occurred in restrictive containment measures like social isolation, remote work, and the closure of businesses that created operational difficulties.
US Pancreatic Cancer Treatment Market Market is poised to grow at a sustainable CAGR for the next forecast year.
To get more reports on the above market click here to Buy The Report
Global pancreatic cancer treatment market is segmented on the basis of treatment type, diagnosis, route of administration, end-user, distribution channel, and region. Based on treatment type, the market is segmented into chemotherapy, targeted therapy, immunotherapy, hormone therapy, others.
Based on diagnosis, the market is segmented into blood test, biopsy, imaging tests, others. By route of administration, the market is segmented into oral, parenteral, and others. By end-user, the market is segmented into hospitals, specialty clinics, homecare, and others. By distribution channel, the market is segmented into hospital pharmacy, retail pharmacy, online pharmacy, and others. Based on region, the pancreatic cancer treatment market segmentation spans North America, Europe, Asia-Pacific, South America, and MEA.
Pancreatic Cancer Treatment Market Analysis by Treatment Type
Targeted therapy dominated the market in 2022 and is expected to continue to do so during the forecast period. Targeted therapy occupied the largest share since it is considered as the most effective treatment option, which blocks the growth and spread of cancer cells without damaging healthy cells. The introduction of novel biologic therapies and targeted drugs to reduce the side effects of existing therapies, such as chemotherapy, is one of the factors driving growth.
To get detailed analysis on other segments, Request For Free Sample Report
With the highest revenue share in 2022, North America dominated the pancreatic cancer treatment market. This region's dominance is primarily due to improved healthcare infrastructure, widespread adoption of pancreatic treatment procedures, and the presence of a large target population. Furthermore, the rising incidence of pancreatic cancer is driving up demand for treatment options. By authorising medications in the clinical phase and so hastening clinical advances, the USFDA is also taking steps to boost the development of the pancreatic cancer treatment market.
The market in Asia Pacific is expected to grow the fastest during the forecast period. The presence of well-established hospitals and critical care centers, as well as a large population suffering from pancreatic cancer, would drive the Asia Pacific market's growth. Furthermore, with the increasing number of pancreatic cancer cases in the Asia Pacific, pancreatic cancer diagnosis and treatment in the region must follow the same protocol as in Western countries.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Pancreatic Cancer Treatment Market Drivers
Rise in cases of cancer and need for ultra care is expected to accelerate the market growth
Pancreatic Cancer Treatment Market Restraint
Significant costs of treatment and lack of healthcare infrastructure at remote locations to impede the market growth
Request Free Customization of this report to help us to meet your business objectives.
The pancreatic cancer treatment market is fiercely competitive, and few major companies dominate it. The competition is getting more intense due to the presence of major market players. The market participants are implementing methods including increased R&D spending, mergers, acquisitions, and product developments.
Top Players in the Global Pancreatic Cancer Treatment Market
Pancreatic Cancer Treatment Market Recent Developments
In January 2022, for pancreatic cancer treatment, the U.S. Food and Drug Administration (FDA) gave orphan drug status to multitargeted T-cell therapy. This therapy has shown the potential to elicit sustained responses in individuals with advanced or metastatic pancreatic cancer when combined with chemotherapy as a first-line therapeutic option.
In February 2022, Eli Lilly and Company and UNICEF declared a collaboration aimed at improving healthcare facilities for around 10 million children and adolescents suffering from non-communicable diseases.
Increase in R&D activities: Rise in the R&D activities is fueling the market expansion. This will present advantageous chances for the expansion of the market for treatments for pancreatic cancer. Along with this, an increase in drug releases and approvals will speed up the market's expansion.
Increase in investments: Additionally, the growing investments in the creation of cutting-edge technologies and an increase in the quantity of emerging markets will create more favourable conditions for the expansion of the pancreatic cancer treatment market over the forecast period.
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates and Analyses the Data collected by means of Primary Exploratory Research backed by the robust Secondary Desk research.
According to the pancreatic cancer treatment market report analysis, by treatment, the targeted therapy segment has the largest revenue share in 2022. Region-wise, North America dominated the global market in terms of market share and size and is attributable to a dominant position owing to presence of established players and availability of state-of-the-art treatment.
Report Metric | Details |
---|---|
Market size value in 2022 | USD 2.15 billion |
Market size value in 2031 | USD 6.85 billion |
Growth Rate | 15.7% |
Base year | 2023 |
Forecast period | 2024-2031 |
Forecast Unit (Value) | USD Billion |
Segments covered |
|
Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
Companies covered |
|
Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
For the Pancreatic Cancer Treatment Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Pancreatic Cancer Treatment Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Pancreatic Cancer Treatment Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Pancreatic Cancer Treatment Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Report ID: SQMIG35I2262
sales@skyquestt.com
USA +1 351-333-4748